Medical News Today -
26 Jan 2014 10:00
The presence of sickle cell trait among African Americans may help explain why those on dialysis require higher doses of an anemia medication than patients of other ethnicities, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Additional studies are needed to determine the long-term health consequences of this increased dosing.Sickle cell trait represents the carrier state of sickle cell disease and is present in roughly 6% to 8% of...
Share this Article